Explorative Cardiovascular News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bayer, National Heart Center Singapore to develop explorative cardiovascular center By Anh Nguyen   December 22, 2020 | 04:43 pm GMT+7 Bayer and National Heart Center Singapore (NHCS) announced they had inked a five-year agreement to develop a “Center of Excellence for Explorative Cardiovascular Studies.” The center aims to boost patient-centricity in research and development (R&D) and improve treatment outcomes in cardiovascular disease (CVD) management. Combining NHCS’s vast experience in managing Asian CVD patients and clinical research with Bayer’s expertise in pharmaceutica...

Bayer and NHCS to set up Centre of Excellence for Explorative Cardiovascular Studies 17:03 | 18/12/2020 Bayer and National Heart Centre Singapore today announced that they have entered into a 5-year collaboration agreement to set up a Center of Excellence for Explorative Cardiovascular Studies. Bayer and NHCS will collaborate on forming a better understanding of cardiovascular diseases in Asian patients. Photo: Freepik Bayer and National Heart Centre Singapore (NHCS) will establish a Center of Excellence for Explorative Cardiovascular Studies with the aim of bo...

 E-Mail Leveraging on Asian patient data, the 5-year collaboration aims to boost patientcentricity in R&D, leading to improved treatment outcomes in cardiovascular disease (CVD) management. The Center will generate and integrate high quality patient data into early clinical research to inform future targeted therapies for CVDs. Bayer will contribute S$5.4million (approx. EUR 3.4 million) towards this collaboration. Singapore, December 17, 2020 - Bayer and National Heart Centre Singapore (NHCS) today announced that they have entered into a 5-year collaboration agreement to set up "Center of ...